全文获取类型
收费全文 | 60454篇 |
免费 | 4380篇 |
国内免费 | 2138篇 |
专业分类
耳鼻咽喉 | 382篇 |
儿科学 | 1409篇 |
妇产科学 | 740篇 |
基础医学 | 8992篇 |
口腔科学 | 791篇 |
临床医学 | 4599篇 |
内科学 | 9419篇 |
皮肤病学 | 1160篇 |
神经病学 | 4802篇 |
特种医学 | 861篇 |
外国民族医学 | 11篇 |
外科学 | 4443篇 |
综合类 | 6404篇 |
现状与发展 | 10篇 |
预防医学 | 4916篇 |
眼科学 | 996篇 |
药学 | 10349篇 |
8篇 | |
中国医学 | 3075篇 |
肿瘤学 | 3605篇 |
出版年
2023年 | 877篇 |
2022年 | 1496篇 |
2021年 | 1916篇 |
2020年 | 1808篇 |
2019年 | 2388篇 |
2018年 | 2342篇 |
2017年 | 1977篇 |
2016年 | 1899篇 |
2015年 | 2098篇 |
2014年 | 3276篇 |
2013年 | 4021篇 |
2012年 | 3400篇 |
2011年 | 4057篇 |
2010年 | 3382篇 |
2009年 | 2793篇 |
2008年 | 2643篇 |
2007年 | 2481篇 |
2006年 | 2104篇 |
2005年 | 1835篇 |
2004年 | 1635篇 |
2003年 | 1512篇 |
2002年 | 1245篇 |
2001年 | 1091篇 |
2000年 | 832篇 |
1999年 | 851篇 |
1998年 | 697篇 |
1997年 | 646篇 |
1996年 | 556篇 |
1995年 | 487篇 |
1994年 | 437篇 |
1993年 | 409篇 |
1992年 | 371篇 |
1991年 | 348篇 |
1990年 | 306篇 |
1989年 | 247篇 |
1988年 | 243篇 |
1986年 | 183篇 |
1985年 | 806篇 |
1984年 | 1036篇 |
1983年 | 821篇 |
1982年 | 941篇 |
1981年 | 888篇 |
1980年 | 662篇 |
1979年 | 619篇 |
1978年 | 444篇 |
1977年 | 356篇 |
1976年 | 408篇 |
1975年 | 311篇 |
1974年 | 193篇 |
1973年 | 196篇 |
排序方式: 共有10000条查询结果,搜索用时 24 毫秒
41.
B. J. M. Vlaminckx W. van Pelt J. F. P. Schellekens 《Clinical microbiology and infection》2005,11(7):564-568
A nationwide laboratory-based surveillance system for invasive group A streptococcal (GAS) infections was conducted in The Netherlands from March 1992 until December 2003. Until 1996, all isolates submitted were evaluated clinically and demographically. During this period there was a transition from passive to active surveillance for some of the participating laboratories, corresponding to a national coverage of 50%. During active surveillance, participating laboratories submitted twice as many isolates from invasive GAS disease, whereas the relative submission of isolates representing very severe manifestations (toxic shock-like syndrome, fatality) did not increase. From 1997 onwards, invasiveness was defined solely on the basis of source of isolation (without clinical evaluation). During the period of microbiological and clinical evaluation, microbiological evaluation alone was found to be specific (> 99%), but had limited sensitivity (66%). Estimation of the true rate of invasive GAS disease should be based on an active surveillance system with inclusion of both microbiological and clinical data. 相似文献
42.
目的探讨脊髓血管畸形是否存在血管内皮生长因子(VEGF)表达,及其表达与临床特征之间是否存在相关性。方法在手术中留取56例脊髓血管畸形的脑脊液标本,其中动静脉畸形(SCAVM)23例,硬脊膜动静脉瘘(SDAVF)19例,海绵状血管瘤(CM)14例;以我院12例蛛网膜下腔阻滞病人脑脊液作为对照组,分别通过酶联免疫吸附方法(ELISA)测定脊髓血管畸形脑脊液中VEGF含量。结果SCAVM脑脊液中VEGF浓度为(277±66)pg/ml、SDAVF为(318±54)pg/ml、CM为(146±32)pg/ml均高于正常对照组(123±27)pg/ml。术前栓塞和出血均可导致脑脊液VEGF升高。结论VEGF与脊髓血管畸形的发生、发展存在一定关系,出血和栓塞均可影响VEGF的表达。 相似文献
43.
Martin A Ritter Achim Frese Rainer Dziewas Stefan Knecht Stefan Evers 《Movement disorders》2006,21(10):1787-1788
Synkinesias secondary to nerve lesions and aberrant re-innervation are well-known phenomena especially after lesions of the facial nerve. Synkinesias can successfully be treated with botulinum toxin A (BTx A). Synkinesias of the cremaster muscle have not been described or treated to date. We present the case of a 62-year-old man who developed synkinesias of both cremaster muscles after extensive laparatomy for esophageal cancer. Treatment of synkinesias with various oral medications had been unsuccessful. Electromyography-guided injections of BTx A in both cremaster muscles (15 MU on the right and 10 on the left) led to significant symptom relief for an average of 8 weeks. We present the case including pre- and posttreatment video clips. 相似文献
44.
目的 大量富集三裂叶蟛蜞菊倍半萜内酯A,B(WTA,WTB)。方法 采用气相色谱法测定WTA和WTB,并以WTA和WTB的含量、洗脱率、精制度为考察指标,研究D101大孔树脂吸附WTA和WTB的工艺条件及参数。结果 通过大孔树脂吸附后,WTA和WTB的洗脱率达90%,50%乙醇洗脱部分中WTA和WTB的含量为总固物的4.01%~4.09%。结论 可以采用大孔树脂富集WTA和WTB。 相似文献
45.
D. M. Wolf R. Rokicka-Milewska† S. Lopaciuk† A. B. Skotnicki§ A. Klukowska† P. Laguna† J. Windyga‡ R. Kotitschke W. G. Struff 《Haemophilia》2004,10(5):438-448
Clinical efficacy, safety and pharmacokinetic properties of the high-purity double-virus inactivated plasma-derived factor VIII concentrate Haemoctin SDH (pdFVIII) were evaluated in three prospective open-label uncontrolled studies in previously treated patients (PTPs) with severe haemophilia A. The pharmacokinetic properties assessed at baseline and after 3 months of treatment are in accurate accordance with published data and remain unchanged over time (study A, n = 12). Mean terminal elimination half-life was 11.8 and 11.9 h, mean incremental recovery (IU dL(-1)/IU kg(-1)) was 2.3 and 2.0, respectively. Long-term efficacy and safety, in particular the potential immunogenicity, were investigated in a total of 53 PTPs (studies A and B) treated prophylactically and on-demand, as required. PdFVIII has shown to be effective in preventing and controlling bleeding episodes; 23.5% of patients were free of bleeding events. A total of 177 haemorrhages occurred with 74.0% resolving after a single infusion, 87.6% within two infusions. 98.3% of responses reported on haemorrhages were rated as 'excellent' or 'good'. Moreover, 'excellent' haemostatic efficacy has been demonstrated in 10 surgical procedures including general and severe orthopaedic interventions (study C). No complication occurred in any surgery. Few adverse events were reported, one patient developed a high-titre FVIII inhibitor without clinical relevance. In all three studies, over 6 million units were administered in nearly 4300 infusions, approximately 94% units or infusions were given for prophylaxis and only 6% for treatment on-demand. In conclusion, pdFVIII has shown to be effective, safe and well tolerated in long-term prophylaxis and treatment on-demand as well as after minor and major surgical procedures. 相似文献
46.
Early multiple organ dysfunction syndrome appears to be facilitated with bacterial translocation in severely burn injury, yet the mechanisms of bacterial translocation remains in dispute. The aim of this study was to investigate the potential role of intestinal bifidobacteria in the pathogenesis of gut-derived bacteria/endotoxin translocation following burns and the effects of bifidobacterial supplement on gut barrier. Methods: Wistar rats were randomly divided into burn group (Burn, n=60),sham burn group (SB, n=10) in experiment Ⅰ , and burn + saline group (BS, n=30), burn + bifidobacteria group (BB, n=30), and sham-burn + saline group (SS, n= 10) in experiment Ⅱ. Animals in BB group were fed bifidobacterial preparation (5 × 109 CFU/ml) after burns, 1.5ml,twice daily. Animals in BS and SS were fed saline. Samples were taken on days 1, 3, and 5 in burn groups, and on day 3 in sham-burn groups. The incidence of bacteria/endotoxin translocation and counts of Bifidobacterium, Fungi and Escherichia coli in gut mucosa were determined with standard methods. The levels of sIgA in mucus of small intestine were measured by RIA. The positive sIgA expression in lamina propria and ileum mucosal injury was evaluated light microscopically by blinded examiners. Results: Our results showed that the incidence of bacterial translocation was increased after burns, which was accompanied by significant decrease in number of bifidobacteria but significant increase in E. coli and fungi in gut mucosa, and elevation of levels of plasma endotoxin and IL-6 (P<0. 001).The incidence of bacterial translocation was markedly reduced after 3- and 5-day supplementation of bifidobacteria compared with control group (P<0.05). The counts of mucosal bifidobacteria were increased by 4- to 40-fold,while E. coli and fungi were decreased by 2- to 30-fold and 10- to 150-fold, respectively, after bifidobacterial supplementation in contrast to control group. The damage of mucosa tended to be less pronounced after 3-day bifidobacteria-supplemented formula compared with control group [grade 2(0-6) vs. grade 4(3-6), P<0.05]. Moreover, the expression and release of sIgA was markedly augmented after 3-day bifidobacteria-supplementation formula and it returned to normal range on day 5. Conclusion: The decrease in counts and proportion of bifidobacteria in mucous membrane flora may play an important role in the development of bacteria/endotoxin translocation following thermal injury. The supplement of exogenous bifidobacteria could per se improve gut barriers, and attenuate bacteria/endotoxin translocation secondary to major burns. 相似文献
47.
目的:研究蛇毒Ⅱ类磷脂酶A2(PLA2)中D49 PLA2和K49 PLA2的功能分化及其功能分化决定位点的鉴定。方法:运用序列比较分析,进化树构建和DIVERGE v1.04软件计算研究D49 PLA2和K49 PLA2的功能分化情况及其分化位点。结果:序列比较分析,进化树构建和DIVERGE v1.04软件计算结果表明蛇毒Ⅱ类PLA2中D49 PLA2和K49 PLA2的确发生了功能分化,对于K49 PLA2来说,1S,7K,11Q,E12,R34,T56,N88,L92,E108,K116,K128可能为功能分化决定位点。对于D49 PLA2,L2,G33,G35,F46和Y118可能为功能分化决定位点。结论:我们首次通过序列比较分析,进化树构建和DIVERGE v1.04软件计算鉴定出蛇毒Ⅱ类PLA2中D49 PLA2和K49 PLA2可能的功能分化位点,为今后通过基因重组和定点突变方法研究蛇毒Ⅱ类PLA2结构功能关系提供了线索。 相似文献
48.
J. K. Brown P. A. Knight S. H. Wright E. M. Thornton H. R. P. Miller 《Clinical and experimental allergy》2003,33(1):132-146
BACKGROUND: The mucosal mast cell (MMC) granule-specific beta-chymase, mouse mast cell protease-1 (mMCP-1), is released systemically into the bloodstream early in nematode infection before parasite-specific IgE responses develop and TGF-beta1 induces constitutive release of mMCP-1 by homologues of MMC in vitro. Intraepithelial MMC may also express the chemokine CCL2 (monocyte chemotactic protein-1) during nematode infection but the expression of this chemokine by MMC homologues has not been investigated. OBJECTIVE: To investigate the expression and to compare the mechanisms of constitutive release of the chymase, mMCP-1, and the chemokine, CCL2. METHODS: MMC homologues were generated by culturing bone marrow cells in the presence of TGF-beta1, IL-3, IL-9 and stem cell factor (SCF). The intracellular distribution of mMCP-1 and CCL2 was examined by confocal microscopy. The involvement of the Golgi complex and of protein synthesis in the constitutive release of mMCP-1 and CCL2 was investigated using the Golgi-disrupting agent brefeldin A and cycloheximide to block protein synthesis. Secreted analytes were quantified by ELISA. RESULTS: mMCP-1 colocalized with Golgi matrix protein 130 but was most abundant in the granules, whereas CCL2 was not found in the granules but appeared to be located uniquely in the Golgi complex. Extracellular release of mMCP-1 was significantly inhibited ( approximately 40%) by cycloheximide and by the Golgi-disrupting agent brefeldin A, indicating both continuous protein synthesis and transportation via the Golgi complex are required for optimal mMCP-1 secretion. A similar but more marked inhibitory effect with both compounds was demonstrated on the constitutive secretion of CCL2. CONCLUSION: The culture conditions that promote mMCP-1 expression and release by MMC homologues also promote the expression and release of CCL2. Constitutive release involves de novo protein synthesis and requires a functional Golgi complex, suggesting that similar mechanisms of extracellular secretion operate for both mediators. 相似文献
49.
高效液相色谱法测定石杉碱甲片的含量 总被引:2,自引:0,他引:2
采用高效液相色谱法测定石杉碱甲片的含量。固定相为μBondapak C18,流动相为乙腈-0.02mol/L磷酸二氢钾溶液(12:88),以对乙酰氨基酚为内标,石杉碱甲浓度在10 ̄50mg/L范围内与峰面积呈良好的线性关系,平均回收率为99.93%,RSD为0.41%(n=9)。 相似文献
50.
观察硒和维生素A(VA)对支原体肺炎的治疗效果.方法 采用双盲随机对照2×2析因实验设计,选择100例住院支原体肺炎患儿,分为补硒组26例,补VA组23例,补硒和VA组30例以及病例对照组21例,正常组21例.一次补硒量为1mg亚硒酸钠和/或15万单位VA,对照病例组给予常规治疗.结果 与对照组比,治疗后3个补充组的症状和体征缓解天数均有不同程度缩短(P<0.05),补硒组白细胞硒和谷胱甘肽过氧化物酶水平显著上升(P<0.05),补VA、补硒组血清VA水平上升(P<0.01),细胞免疫功能有所改善.结论 硒和VA有协同作用,补充硒或同时加VA,作为辅助治疗支原体肺炎的方法,安全、有效. 相似文献